Dawn Matthews, MS MBA, Chief Executive Officer, brings 30 years of life science management experience and over 15 years in neuroimaging clinical trials. With leadership and direct contributing roles to ADMdx’ technical development and imaging operations, she has presented at numerous conferences and is co-author of several papers and book chapters focusing on neuroimaging in Alzheimer’s Disease. She is co-lead for the imaging section of the Radiologic Society of North America Quantitative Biomarkers amyloid profile working group, and co-chair of the Imaging Biomarkers group of the Critical Path for Parkinson’s Consortium (CPP). She received her MS in Electrical Engineering at the University of Michigan, her BS in Electrical Engineering at the University of Notre Dame, and her MBA at Northwestern University.
Stephen C. Strother, PhD, VP & Chief Science Officer, has over 30 years of experience in the development of imaging technologies, specializing in functional neuroimaging. He has been a prominent proponent of predictive modeling approaches to analysis of functional brain images, having developed the NPAIRS software package. He is chair of the Data Format Working Group, a multinational committee set up under the Neuroimaging Informatics Technology Initiative at the NIH. Dr. Strother is also a Senior Scientist at the Rotman Research Institute and Professor of Medical Biophysics at the University of Toronto, and Associate Editor of the journal Human Brain Mapping.
Miles N. Wernick, PhD, VP & Chief Technology Officer, has over 30 years of experience in the development of imaging technologies. He is an expert in medical imaging, image analysis, and machine learning. Dr. Wernick is also the Motorola Endowed Chair Professor at the Illinois Institute of Technology (IIT), where he is Director of the Medical Imaging Research Center. Dr. Wernick is co-editor of the book Emission Tomography: The Fundamentals of PET and SPECT. He is a Fellow of the American Institute for Medical and Biological Engineers. He has served as Associate Editor of the journals IEEE Transactions on Image Processing, Medical Physics, and SPIE/IS&T Journal of Electronic Imaging, is a member of the IEEE BioImaging and Signal Processing Technical Council.
Midori Yokoyama, PhD, MBA, VP Business Operations, brings extensive experience in venture capital investment, pharmaceutical licensing, international business and drug discovery in neurological and psychiatric disorders. Dr. Yokoyama managed a portfolio of biotechnology investments at Société Générale Asset Management in Paris, France, licensing evaluation at TAP Pharmaceuticals (Takeda Abbott joint venture) and Takeda Pharmaceuticals, and strategic investments at Baxter Ventures. She received PhD in neurobiology from Cornell University and MBA from Northwestern University.
Ana Lukic, PhD, VP of Imaging Research and Operations, has led the development of ADMdx’ imaging classifiers and software since its founding, and previously led these activities for Predictek, Inc., an ADMdx parent company. Dr. Lukic was primary architect of ADMdx’ PipelineMAX™ image processing and analysis software platform. She has served as Principal Investigator on multiple NIH and NSF grants including ADMdx’ present SBIR grants, and as project director on numerous imaging studies and analysis collaborations.
Randolph Andrews, MS, Director, Data Management, has extensive expertise in the quality control and processing of PET and MRI images and in the tracking and management of imaging, clinical, and other data. He is responsible for ADMdx’s database that includes over 10,000 images from multiple data sources, and associated clinical, demographic, genotype, and other data. His work allows ADMdx to rapidly mine and analyze data for classifier development and clinical trial planning, and to consistently track clinical trial status. He brings 16 years of experience in addition to an educational background in biology and developmental neuroscience, and as an NCO in the US Army.